list pasien divisi onkologi 8 januari 2015

7/25/2019 List Pasien Divisi Onkologi 8 Januari 2015

1/7

LIST PASIEN DIVISI ONKOLOGI-KL

Sabtu, 9 Januari 2016

IRINA A ATAS (12 a!i"n#

No Kamar Identitas Diagnosis PemeriksaanPenunjang Terapi/rencana KP &

Ket :

1. A1

Bed 2

KandouDe!ried/"/1

# t$n/%2'%

()* 2/12/2+1,

-P 12

Dr. (. (erung

*pB0Knk

3anaso!aring metastase

K4B supraka5ikua

Anemia

6ektroit Im7ance

26$12$201%

"eu '1.'++

6ri 28

-7 #2

-t 2'9

Tro #

(3- 299

(3-3 '%

(3 #82

*4T 2

*4PT %+

;r %8

3r 11

4D* 8,

Na 12'

K '

3 ##+

&0$12$ 201%

"eu 2#.%%+

6ri '+

-7 #9

-t 28%

Trom7o ,8'

(3- 2%1

(3-3 28,

(3 #1,

I,++mg

drips

Bone dronate 1>1 inj

3ek a7 uang

Nikma

2. A'Bed 1

De5?a Agama/ P/%+t$n/

%.21.%9

()* 2'/12/2+1,

-P @ 11

dr. (. (erung

*pB0Knk

3a mammae sinistra stad.IIIB anemia

2'$12$201%"eu %,++

6ri 2.'#

-7 .2

-t 1#.

Trom7o 229

(3- 2.1

(3-3 ''.'

6sino!i'=

Baso!i+=

Netro7tg 1=

Netrosgment

9%=

"im =

(onosit =

0 &$12$1%"euko,,++

6ri2#

-791

-tc2'

Trom7o'9,

(3- 2,

(3-3 '+1

(3 ##.+

3isis

K isis

Na isis

4D* 1++

Trans!usi P)3 sampai$7

1+

I 1

)anitidine inj 2 > 1

)/ simpe mastektomi

09/1/1

)atna

1


2/7

%. A

Bed '

*artjeEoor/P/%'

t$n

+8.+1.12

()* 19/12/2+1,

-P 1#

dr. (arse(erung

*pB0Knk

tra

Anemia

20$12$201%

"eu 1++++

6ri 2.%2

-7 ,.,

-tc 1#

Trom7o '#(3- 22.9

(3-3 '+.

(3 9%.2

29$12$201%

"eu 12,2+

6ri %.%8

-7 11.%

-t '.8

Trom7o ,2

(3- 2,.%

(3-3 '+.8

(3 #2.2

*4T 1%*4PT

;r 19

3r +.#

Prot tot ,.82

4D* 11+

A7 2.%9

4o7 '.%,3 #8.'

K '.,'

Na 129

PT 19.%

IN) 1.,%

APTT 29.

&1$12$ 201%

"eu 2'8++

6ri %22

-7 11%

-t '99

Trom7o 98'

(3- 29.+(3-3 '+.2

(3 #8.'

;r #2

3r 1.9

4D* 1'2

3 1++

K 9

Na 122

)anitidine 2>1 ta7

mepraFoe 2>1 caps

IP a7umin sc$t '>1

)/ simpe mastectom?

menunggu jaa7an konsu

interna

)iska$

,. A#

Bed #

Buduna a

engge/"/1t$n/

%.2#.9'

()* +1/+1/2+1

-P #

dr.(arse (erung

*pB0K nk

(eanoma maigna

dengan metastase K4B

eektroit im7aance

01$01$2016

"eu 92++

6ri %2#

-7 118

-tc '82

Trom7o 2''

*4T 2+9

*4PT %

;r 1#

3r +

4D* #1

3 8'+

K 2.8+

Na 129

I1

Ketoroac inj '>1

3e!tria>one inj 2>1 gr

r/ ec$o

r/ kemoterapi

)a$mat

. A# ii

sukiman/"/,1t$n/%%.

%.+

()* +%/+1/2+1

-P ,

dr.(arse (erung

*pB0K nk

3acoi anapastic post op

)/ Kemoterapi

6ndrio

9. A2 *u$artati

Bakari/P/9t$n/

''.+1.,+

()* +%/+1/2+1

-P ,

dr.(arse (erung

*pB0K nk

3a mamma sinistra &0$12$1%

"eu 9,29

6ri '#+

-7112

-t''%

Trom7o 28#

(3- 28%

(3-3 '',

(3 ##

3 81%

K %1+

Na 1',

)/kemoterapi Diana

2


3/7

#. A

Bed 2

(arnita

"am7a/P/%%t$n/

%,.2.,%

()* +%/+1/2+1

-P %

dr.(arse (erung

*pB0K nk

3a mamma de>tra

stad.IIIB

)/kemoterapi )atna

8. ABed #

*eroan*tans/P/,%t$/ %.12.18

()* +,/+1/2+1

-P %

dr. (.(erung

*pB0Knk

Tumor coi %$1$16"eu #8++

6ri %,'

-7 11%

-t ',2

Trom7o 2+'

(3- 2,2

(3-3 '2%

(3 999

*4T ,9*4PT '1

;r %2

3r 1,

4D* 11'

Na 1'2

K %%

3 88

Ione 2>1 gr i5

)anitidine 2>1 amp i5

Ketoroac '>1amp i5

)iska$

1+. A1+ (aisiou

Ho$n?/"/9

t$/%.1,.,8

3a Naso!aring )/kemoterapi )a$mat

11. A (artini (adeu/P/

%8t$/ %,.2.#,

3a mammae )/kemoterapi 6ndrio

12 Pata7uga Nispa/P/

% t$/ %%.+9.1

3a mammae *tatus Nikma

IRINA A AA.(10 PASIEN#

No Kama

r

Identitas Diagnosis PemeriksaanPenunjang Terapi KP &Ket:

1. B2

Bed 1

JutjeAtang/P/,#t$n/

'9.'.%,

()* 1,/12/2+1,

-P@29

dr. (arse(erung

*pB0Knk

*o!t tissue sarcoma

region genu sinistra

2/$12$201%

"eu '++

6ri '.++

-7 8.+

-t 29.'

Trom7o 22%

(3- '+.+

(3-3 ''.+

(3 81.+

(aaria

0negati5e

2'$12$201%

"eu%%++

6ri'1%

-7 8'

Trom7o 19#

4T 119

4PT '8

;r 29

3r 1'

3 ##8

K '2

Na 12,

&0$12$ 201%

Urinalisis

Dara$

Protein

0/$01$ 201 6

"eu 11++

6ri '.'

-7 8.9

-t 2,.9=

Trom7o '%#

(3- '%#

(3-3 2#.8

6os '=

Bas +=

Net.B 2=

Net.* +=

"im! '+=

(onosit ,=

(3 9.,

-BA13 9.9=

3 99.#

K. 2.+'

Na 122

NA

(engara$ pada

proses

(aignasi

3enderung

sarkoma ?ang

jenisn?a sukar

di tentukan.

I


4/7

()* +,/+1/2+1

-P ,

dr.Nico "

*pB0KK"

!ronta D !r. Basis

cranii !r. (a>ia D

6ri %#2

-7 1%#

-t %1+

Trom 2+#

(3- '+9

(3-3 '1

(3 #,1

;r 2+

3r 1+

4D* 1%9

3 1+,+

K ',+

Na 1'#

"epas )aat ;ntuk

*ementara

Insuin sesuai T*

Interna

Ione 2>1 gri5

)anitidine 2>1 amp

i5

'. B%

Bed 1

*utria$/P/,#t$n/

'9.'.%,

()* 1,/12/2+1,

-P@2

dr. (arse(erung

*pB0Knk

*o!t tissue tumor

regionante7rac$ide>tra

0/$1$16

"eu ,#++

6ri 2#-7 9'

-t 2+9

Trom7o %+

(3- 21

(3-3 ','

(3 9'8

;r 1,

3r 1'

4D* 9

A7 2%

Na 1''

K %9#

3 8#'

01 $01 $201%

"eu,#++

6ri2.#+-79.'

-t2+.9

Trom7o%+

(3- 2.1

(3-3 ',.'

(3 9'.+

;r 1,

3r 1.'

4D* 9

A7 2%

3 8#.'

K %.9#

Na 1''

Ione 2>1 gr i5

Ketorooak '>1 ampI

)anitidine 2>1 amp

I

(enunggu$asi ()I

ante7rac$iide>tra

)atna

%. B,

Bed 1

Aimudin "A/ "/ '9

t$n/ %%.%'.22

()* +,/+1/2+1

-P ,

dr.(.(erung*pB0K

nk

*usp. r$a7domiosarcoma %$1$2016

"eu 28++

6ri ''1

-7 #%

-t 2%#

Trom'#

(3- 2,%

(3-3 ''8

(3 9%8

*4T '2

*4PT 2

;r 1

3r 1%

4D* '

Na 1'1

K '1

3 88

Ione 2>1 gr i5

Ketoroac '>1 amp i5

)anitidine 2>1 amp

i5

Tran!usi P)3 sampai

-B 1+

6ndrio

,. B9

Bed

aentino

Pangke?/12t$n/

%2'99

()* 2/12/2+1,

-P 1,

Dr. N. "umintang

*pB0KK"

1 amp i5

)anitidine 2>1 amp

i5

)iska$

. B 9

Bed #

A5in

aoruntu$/"/12

t$n/

()* 2/12/2+1,

-P 1,

*A- temporoparieta D

1gr

Ketoroac '>1 amp 0Kp

)anitidine 2>1 amp

)a$mat

4


5/7

Dr. N. "umintang

*pB0KK"

*4T 28

*4PT 1

;r 19

3r +#

4D* 1%9

Na 1%+

K ',

3 1+

(3- 292

(3-3 '18

(3 #,1

*4T 1

*4PT 8

;r 2'

3r +#

3 1+%+

K %2+

Na 1'

0/$01$ 201%

PT 1%.%

APTT '%.'

IN) 1.18

T> ain sesuai T* N*

9. B1+

Bed

)a$manAmina/P/%+

t$n/%.2,.'2

()* +,/+1/2+1

-P ,

dr.(.(erung*pB0K

nk

3amamaesinistra r/ kemoterapi

#. B1+Bed 9 Hu Topi/P/,, t$n%.18.,,

()* 2+/12/2+1,

-P@2+

dr. (arse(erung

*pB0Knk

3a(ammae D0T%N1(>

metastaseketuang7eakan

g.

21$12$201%"eu #+++

6ri '.,'

-7 89

-tc 28.1

Trom7o '#

(3- 29.,

(3-3 ''.'

(3 #2.,

;r %+

3r 1.,

4D* 81

(g 2.+#

3 1+2.1

K '.,2

Na 1'9

3a #.%

SG;*4

028/12/2+1,

A7domen saat

ini kesan tak

tampak

keainan

0&$01$201%

"eu ,%++

6ri '.,#

-7 1+.+

-t '2.'

Trom7o ''#

(3- 29.8

(3-3 '1.+

(3 8+.2

*4T %'

*4PT 1'

;r 1%

3r +.#

4D* 1+8

3 88.+

K 2.'+

Na 1'1

Ione inj 2>1

Ketoroac '>1 amp

)anitidine 2>1 amp

it 3 1>1 amp

)/ kemoterapi

Best$

8. B1+

Bed #

(arsaduAnatje/P/%,t

$/'#.%%.9%

()* +%/+1/2+1

-P@

dr.Nico"*pB0KK"

A7ses guteus sinistra 0 /$0 1$2016

"eu 22.%++

6ri '9#

-7 89

-t 292

Trom7o ,8,

(3- 2,9

(3-3 ',9

(3 92

;r 82

3r 1#

4D* %21

Na 1''

K %

3 1++

0 $0 1$2016

"eu1,.9++

6ri2.82

-7 9,

-t 2'%

Trom7o %,

(3- 2,9

(3-3 '21

(3 #+.+

;r %9

3r 1%

"D- 28

Na 1',

K '%#

3 1+%,

&0$12$ 201%

Urinalisis

Dara$

"eukosit

Ione 2>1 gr i5

(etronidaFoe drips

'>,++mg i5

Ketoroac '>1 amp i5

T> ain sesuai T*

interna

6ndrio

5


6/7

1+ B#

Bed 9

;mar A7it /' t$/

%,.92.82

Ameo7astoma

ma>ia de>tra

6-1-2-16

"eu 8+++

6ri '.8%

-7 : 11.1

-t : ',.1

Tro : 2%9

)iska$

ANGGREK 1 (1 PASIEN#

N) Ka3ar I4"ntita! Dia+n)!i! P"3"ri5!aanP"nunan+ T"rai KP 7K"t

1. B8 )i7ka7utuo/P/, t$/+2.,1.+

()* +/+1/1

-P @ %

Dr. ictor Ponto$ *p. B

0kNK

3amammaede>tra post

()(kemoterapi

6!usi peura de>tra

0$01$2016

"eu 11'++

6ri %.92

-7 1'.

-t %2.9

Trom7o 289

(3- 2#.#

(3-3 '1.8

(3 8+.,

*4T 28

*4PT %'

;r '#

3r 1.2

4D* 1,9

Na 1'%

K '.#+

3 1+1.+

Pungsi 6!usi Peura *itoogi

Kemoterapi

I1 ta7

-ari ini Periksa D"

ratna

6


7/7

1. Bed , ;mar A7id/"/,' t$n

%,.92.92

()* +'/12/2+1,

-P '1

dr. (arse(erung

*pB0Knk

Post su7tota

ma>iectom?ecameo7astoma

ma>ia sinistra

0'$12$201%

;r 12

3r +.#

NA

(engara$Ameo

7astoma

EKG

*inus Takikardi

"-otage Aritmia

26$12$201%

"eu 9++

6ri %'2

-7 11

-t '9,

Tro 2#1

*4T 1#

*4PT 1,

;r 1'

3r +#

4o '%

3 8#K '#

Na 1'2

%$1$2016

"eu 9%++

6ri %2+

-7 11#

-t '%#

Tro 2#8

(3- 2#1

(3-3 ''8

(3 #28

;r 11

3r +#4D* #'

3 82

K '8,

Na 12#

6$1$16

"eu 8+++

6ri '8%

-7 111

-t ',1

Trom7o 2%9

(3- 2#2

(3-3 '1

(3 #82

I

list pasien divisi onkologi 8 januari 2015

Documents